Vaccines can prevent certain diseases, reduce the spread of illness, and improve public health. The publisher has analyzed that the demand for human vaccines in Vietnam is steadily increasing. However, due to limited domestic production capacity, Vietnam's human vaccine market mainly relies on imported products. In recent years, Vietnam has imported a large number of vaccines, including COVID-19 vaccines, influenza vaccines, HPV vaccines, and quadrivalent and hexavalent pediatric vaccines. The demand for vaccines in Vietnam is high, especially in the post-COVID-19 era, as both the government and the public place greater emphasis on health, leading to an increase in the number of imported human vaccines.
The vaccine industry involves upstream sectors such as raw material supply (e.g., antigens, adjuvants), manufacturing (including research, production, and quality control), and downstream sectors like distribution and vaccination services. Vaccine production requires strict hygiene conditions, advanced production equipment and technology, and high standards of quality control. Leading global vaccine producers and exporters are typically large biopharmaceutical companies with strong R&D capabilities, such as Pfizer, Moderna, and AstraZeneca. Currently, Vietnamese domestic companies are only able to produce a limited variety of vaccines.
During the COVID-19 pandemic, Vietnam imported a significant number of vaccines to meet the urgent demand. According to the analyst, because of the underdeveloped infrastructure and technology for human vaccine production in Vietnam, the country is heavily reliant on the international market for supply. Moreover, the Vietnamese government is highly committed to public health, promoting higher vaccination rates through the National Immunization Program (NIP), which covers a range of common infectious diseases. Vietnam has entered into cooperation agreements with various international vaccine suppliers to ensure a stable supply of vaccines.
Based on data, in 2023, Vietnam's total imports of human vaccines reached USD 470 million. From January to May 2024, Vietnam's total vaccine imports exceeded USD 250 million, representing a year-on-year growth of over 30%. This trend is expected to continue at a steady growth rate in the coming years.
This analysis reveals that from 2021 to 2024, Vietnam's primary sources of human vaccine imports were the United States, France, and Belgium. Major companies exporting human vaccines to Vietnam include GlaxoSmithKline Biologicals S.A., Merck Sharp & Dohme (Asia) Ltd., and Sanofi Pasteur.
The main importers of human vaccines in Vietnam are pharmaceutical companies, distributors, and logistics providers, mostly foreign enterprises, such as GSK Pharma Vietnam Company, MSD HH Vietnam Ltd., and Sanofi-Aventis Vietnam Company.
Overall, with Vietnam's growing population and rising economic level, coupled with increased awareness of health, the size of Vietnam's human vaccine market is set to expand. This analysis indicates that due to the relatively low production capacity and technological levels of domestic human vaccines, Vietnam's human vaccine imports are expected to continue growing in the coming years.
Topics covered:
- The Import and Export of Human Vaccines in Vietnam (2021-2024)
- Total Import Volume and Percentage Change of Human Vaccines in Vietnam (2021-2024)
- Total Import Value and Percentage Change of Human Vaccines in Vietnam (2021-2024)
- Total Import Volume and Percentage Change of Human Vaccines in Vietnam (2024)
- Total Import Value and Percentage Change of Human Vaccines in Vietnam (2024)
- Average Import Price of Human Vaccines in Vietnam (2021-2024)
- Top 10 Sources of Human Vaccines Imports in Vietnam and Their Supply Volume
- Top 10 Suppliers in the Import Market of Human Vaccines in Vietnam and Their Supply Volume
- Top 10 Importers of Human Vaccines in Vietnam and Their Import Volume
- How to Find Distributors and End Users of Human Vaccines in Vietnam
- How Foreign Enterprises Enter the Human Vaccines Market of Vietnam
- Forecast for the Import of Human Vaccines in Vietnam (2024-2033)
Table of Contents
Companies Mentioned
- GlaxoSmithKline Biologicals S.A.
- Merck Sharp & Dohme (Asia) Ltd.
- Sanofi Pasteur
- Gsk Pharma Vietnam Company
- Msd Hh Vietnam Ltd.
- Sanofi-Aventis Vietnam Company
Methodology
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | October 2024 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 600 Million |
| Forecasted Market Value ( USD | $ 988.16 Million |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Vietnam |
| No. of Companies Mentioned | 6 |
